Furthermore, the expression of CD276 was found to be similar in different tumor stages for certain types of cancers, and the differences were not statistically significant, including CESC, lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), mesothelioma (MESO), SKCM, testicular germ cell tumors (TGCT) and uterine carcinosarcoma (UCS) (Supplementary Fig. S3). This evidence concerns the gene CD276 and neoplasm.